Background: Conventionally, parametric models were used for health state valuation data. Recently, researchers started to explore the use of nonparametric Bayesian methods in this area. Objectives: We present a nonparametric Bayesian model to estimate a preferencebased index for two condition-specific five-dimensional health state classifications, one for asthma (five-dimensional Asthma Quality of Life Utility Index) and the other for overactive bladder (five-dimensional Overactive Bladder Quality of Life-Utility Index). Methods: Samples of 307 and 311 members of the UK general population valued 99 health states selected from a total of 3125 health states defined by each of the measures using the time trade-off technique. The article presents the results of the nonparametric model and compares it with the original model estimated using a conventional parametric random-effects model. The different methods are compared theoretically and in terms of empirical performance across the two data sets. It also reports the effect of respondent characteristics on health state valuations. Results: The nonparametric models were found to be better at predicting health state values within the estimation sample than without in terms of root mean square error and the patterns of standardized residuals. Some respondent characteristics were found to explain variation in health state values, but these did not have a significant effect on the health states values when estimates were adjusted for sample differences with the general population. Conclusions: The nonparametric Bayesian models are theoretically more appropriate than previously used parametric models and provide better utility estimates from the two condition-specific measures. Furthermore, the model is more flexible in estimating the effect of covariates.
Introduction
Preference-based measures of health-related quality of life are widely used to calculate quality-adjusted life-years (QALYs) for use in cost-effectiveness analyses. There are currently a number of generic preference-based measures, including the EuroQol fivedimensional (EQ-5D) questionnaire [1] , health utilities index 2 (HUI2) and 3 [2, 3] , 15D [4, 5] , Assessment of Quality of Life [6] , Quality of Well-Being [7] , and the six-dimensional health state short form (derived from short-form 36 health survey) (SF-6D) [8] . Condition-specific preference-based measures have also been developed, such as for rhinitis [9] , cancer [10] , erectile dysfunction [11] , overactive bladder [12] , dementia [13] , and urinary incontinence [14] . These measures have standardized multidimensional health state classifications with preference or utility weights elicited from a sample of the general population [15, 16] . Their health state classifications, however, generate a large number of unique health states, so it is not feasible to obtain direct valuations for each health state. Models have to be estimated to predict the values for all states defined by the classification on the basis of direct valuations of a sample of states.
The distribution of health state values generated from time trade-off (TTO) and standard gamble (SG) tasks is typically skewed, truncated, noncontinuous, and hierarchical, and so present a major challenge for conventional statistical modeling [8] . Previous statistical models of these data have met with some success in the SF-6D [8] , the EQ-5D questionnaire [17] , and the HUI2 [18] , but there are concerns with the size of the prediction errors and an apparent systematic pattern in the prediction errors (involving overprediction of the value of the poor health states and underprediction of the value of good health states). Furthermore, these methods are limited in the way they are able to model the effect of covariates on health state values. Covariates are modeled only in terms of their effect on the intercept, and these results in the intercept deviating from unity, which violates the requirement that full health equals one on the conventional full health-death scale used to estimate QALYs. It also makes the unrealistic assumption that covariates have the same effect regardless of the state (e.g., the effect is the same regardless of the severity of the state).
An alternative nonparametric Bayesian method for modeling health state preference data for handling these problems has been developed [19] . This method describes the intrinsic characteristics of individual health state valuation data in a way that is more theoretically appropriate than with previously used parametric models. It is also more flexible to take into account the effect of covariates. This method of modeling has been applied to SF-6D SG health state valuation data [20] and extended to address covariates [21] . It has also been applied to a generic measure for children, the HUI2 UK with SG valuation data [22] . In this article, we report on the application of this method to TTO data for two condition-specific preference-based measures: the fivedimensional Asthma Quality of Life Utility Index (AQL-5D) for asthma and the five-dimensional Overactive Bladder Quality of Life-Utility Index (OAB-5D) for overactive bladder. The results are compared with the conventional random-effect regression models for each data set. This article extends the method to two condition-specific measures and provides important evidence on the advantages of this approach to modeling TTO data.
The second section of this article briefly describes the AQL-5D and OAB-5D valuation studies and the data used in this article. The next section briefly sets out the parametric and nonparametric approaches for health state valuations. The fourth section presents the results from each approach and compares the models in terms of their ability to predict actual values and to estimate the effect of covariates. The last section concludes with a discussion of the results and their implication for future use of these measures and modeling work in this field.
The Valuation Survey and Data Set
The Health State Classifications
AQL-5D
The AQL-5D is a health state classification system [23] developed from the Asthma Quality of Life Questionnaire [24] . The dimensions of the AQL-5D are concern about asthma, shortness of breath, weather and pollution stimuli, sleep impact, and activity limitations ( Table 1) . The health state classification system has five dimensions, each with five levels of severity, with level 1 denoting no problems and level 5 indicating extreme problems. By selecting one level for each dimension, it is possible to define 3125 health states.
OAB-5D
The OAB-5D is a health state classification system [25] developed from the Overactive Bladder Questionnaire [12] . The dimensions of the OAB-5D are urge, urine loss, sleep, coping, and concern ( Table 2 ). The health state classification system has the same structure as the AQL-5D, defining a total of 3125 health states.
The Surveys
The respondents were randomly sampled from the general population using the electoral register of names and address from within South Yorkshire, United Kingdom [11, 12] . The TTO technique was chosen for eliciting preference values, which asks respondents to trade off between length of life and quality of life. The survey used the interviewer-administered TTO-prop method developed by the York Measurement and Valuation Health Group, which uses a "time board" as a visual aid [26] . This version of TTO was selected because it has been shown to be more reliable than a nonprops version [27] . Furthermore, it has been used to value the EQ-5D questionnaire.
The selection of health states was determined by the specification of the model to be estimated. In all 99 health states were selected out of the 3125 possible health states defined by the classification. The selection was on the basis of a balanced design, which ensured that any dimension-level (level λ of dimension δ) had an equal chance of being combined with all levels of the other dimensions. These 99 states were stratified into severity groups on the basis of their total level score across the dimensions (simply the sum of the levels), and then randomly allocated into 14 blocks, so that each block has 7 health states. This procedure ensured that all respondents, who were allocated 1 of the 14 blocks, received a set of states balanced in terms of severity and that each state was valued the same number of times apart from the pits state, which was valued by all respondents (see [11, 12] for more details).
Respondents
Three hundred seven members of the public (response rate of 40%) in South Yorkshire (UK) were interviewed in the AQL-5D survey, and 311 people were interviewed in the OAB-5D survey (response rate of 26.7%). Table 3 shows that the two samples were very similar in terms of their sociodemographic composition. Among the respondents to the AQL-5D survey, 53 (17.3%) had asthma and in the OAB-5D survey, 27 (8.7%) reported experiencing symptoms of urge and 18 (5.8%) reported urine loss for at least some of the time. Overall self-reported health status using the EQ-5D questionnaire was very close to the UK EQ-5D questionnaire norms of 0.85 for females and 0.86 for males [28] . Bladder symptoms caused you to plan "escape routes" to restrooms in public places none of the time 2. Bladder symptoms caused you to plan "escape routes" to restrooms in public places a little of the time 3. Bladder symptoms caused you to plan "escape routes" to restrooms in public places some of the time 4. Bladder symptoms caused you to plan "escape routes" to restrooms in public places a good bit or most of the time 5. Bladder symptoms interfered with your ability to get a good night's rest all of the time AQL-5D, five-dimensional Asthma Quality of Life Utility Index; EQ-5D, EuroQol five-dimensional; OAB-5D, five-dimensional Overactive Bladder Quality of Life-Utility Index.
The Data Set

AQL-5D
times using TTO (range, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] and the worst possible state (OAB-5D 55555) was valued 310 times using TTO (one missing value). Mean TTO health state values ranged from 0.56 for the worst possible state, to 0.91 for state 13321, with an average SD of 0.28.
Modeling
The aim of modeling is to estimate health state utility values for all states defined by each classification. The utility associated with a health state is assumed to be a function of that state; hence, by estimating a relationship between the descriptive system and the observed values we can infer values for all states. In previous models of utility data, we have used parametric relationships with assumptions about functional form, but here we contrast this conventional parametric approach reported by Yang et al. [11, 12] with a more flexible Bayesian nonparametric model. A general model for health state valuations can be described by Kharroubi et al. [19] :
where for i ¼ 1, 2, …, n j and j ¼ 1, 2, …, m, x ij is the ith health state valued by respondent j and the dependent variable y ij is the TTO score given by respondent j for that health state. The general model has two sets of independent, zero-mean, random effect terms: ε ij is a random error term associated with each observation and α j is a term to allow for individual characteristics of respondent j. The interpretation of f X ij ,α j À Á is as the true indifference TTO value that respondent j has for health state X ij . The objective is to obtain a health state utility measure for the population as a whole, and this is generally taken to be the mean of the respondent-level health state utilities across the population. To account for different populations, it is possible to model α j in terms of respondent-level covariates such as age, sex, or socioeconomic factors.
The Parametric Approach
Yang et al. [11, 12] specify the following model for respondent j's health state utility:
where μ and h denote unknown parameters and I X ij À Á is a vector of dummy explanatory variables. In the simplest, no-interactions, case of this model, I X ij À Á is a vector of terms I δλ X ij À Á for each level λ > 1 of dimension δ of the AQL-5D and/or OAB-5D. For example, I 32 X ij À Á denotes dimension δ ¼ 3 (weather and pollution in the AQL-5D; sleep in the OAB-5D), level λ ¼ 2 (experience asthma symptoms as a result of air pollution a little or hardly any of the time in the AQL-5D; bladder symptoms interfered with your ability to get a good night's rest a little of the time in the OAB-5D). For any given health state X ij , I δλ X ij À Á is defined as follows:
In all, there are 25 of these terms, with level λ ¼ 1 acting as a baseline for each dimension. Hence, the intercept parameter μ represents the health state utility value for state (11111), and summing the coefficients θ δλ of the "on" dummies and adding this to the intercept derives the value of any other state.
More generally, I X ij À Á can include additional dummy variables to account for interactions between the levels of different dimensions, and the model selected by Yang et al. [11, 12] included one such term, Interaction dummy in the AQL-5D and N2_severe in the OAB-5D, each of which takes the value of 1 when two or more dimensions in a health state were greater than level 4 and 0 otherwise.
Estimation of this random-effects model is via generalized least squares or maximum likelihood. Because α j has zero mean, the population health state utility for state x in this model is simplyμþĥ 0 I X ð Þ.
The Nonparametric Approach
The Bayesian statistical nonparametric model describes the characteristics of individual health state valuation data in such a way that for respondent j, the health state utility of state X ij is
Note that the individual respondent term α j enters multiplicatively rather than additively as in Equation 2. The term u(x) is the median health state utility of health state x. (In the Kharroubi et al. [19] model, the distribution of α j is normal, so it has zero median as well as zero mean, and the median of exp α j À Á is therefore 1.) It is treated as an unknown function and in the Bayesian framework it therefore becomes a random variable. The prior distribution for u(x) is
Note that x is a vector comprising discrete levels on each of the five health dimensions. Note also that the mean function of Equation 4 represents a belief that the utility will be approximately linear and additive in different dimensions. This is not at all the same thing as model (2) . Although model (2) imposes this linearity and additivity as a strict assumption about the utility function, model (4) simply expresses it as a prior expectation. (It is to be noted that linearity in each dimension is inappropriate because it is not reasonable to suppose that utility should drop by the same amount when we move from level 2 to 3 on a dimension as when we move from level 1 to 2. In the EQ-5D questionnaire, for instance, the levels in each dimension are of the form "no restriction" [in health or ability to function], "some restriction," "severe restriction," and there is no reason to suppose that the step from "none" to "some" has the same health impact as from "some" to "severe." Additivity may also be inappropriate, with some interaction to be expected. Linearity and additivity, however, can be overcome by models using a transformation function, a power or logarithmic function say. More on this is given in Kharroubi et al. [19] .) The actual function is free to vary around this mean according to its multivariate normal distribution, and so it may take absolutely any form. It is in this sense that we describe our model as nonparametric, and we believe that this is another way in which our model is more realistic than that of Yang et al. [11, 12] . See Kharroubi et al. [19] for more explanation of this part of the model. 
where α is the mean value of exp α ð Þ over the whole population. This will not in general be 1, and so the population (mean) health state utility is not the same as the median health state utility
u(x). More details of the nonparametric modeling and evaluation of α are given in Kharroubi et al. [19] .
Note also that the variable α j is allowed to vary because this captures the effect of respondent characteristics. Suppose that t j is the vector of covariates for respondent j, we then propose
where θ is the vector of coefficients for the covariates. Note here that t's are centered to ensure that they have zero means, and hence the value of exp α ð Þ for a typical person is 1. The models and the programs to apply the Bayesian approach have been written in Matlab and are available on request.
Comparison of Models
The two models cannot be compared in terms of a simple table of coefficients as is the case in parametric models because the nonparametric model produces in effect a separate parameter for every one of the 3125 health states. Given the overall aim is to predict health state valuation, the best way to compare these models is via their predictive ability. This includes plots of predicted to actual values, calculations of the root mean squared error (RMSE), and plots of standardized residuals. These assessments are undertaken within the full estimation sample and in an out of sample random selection of 10 states by re-estimating the models using data sets excluding these 10 states.
Results
The predictive ability of the two methods of modeling data is compared in Figures 1 and 2 for the two data sets. Figure 1 presents the predicted mean health state valuations (line marked with squares) for the parametric model (2), along with actual mean health state valuations (line marked with diamonds), with health states ordered by predicted health state values (Figs 1 and 2 have been plotted by ordering states in terms of their predicted values rather than observed values as presented in Yang et al. [11, 12] . This is better on statistical grounds and easier to interpret.). The line marked with triangles represents the errors obtained by the difference between the two valuations. Figure 2 presents the same plots for the nonparametric model. These plots suggest that parametric models have a tendency to overpredict the value of the better states, whereas this does not seem to have been a problem for the nonparametric model. However, there is some suggestion that predictions are below those observed across the board in the OAB AQL-5D, five-dimensional Asthma Quality of Life Utility Index; OAB-5D, five-dimensional Overactive Bladder Quality of Life-Utility Index.
using the nonparametric model (Fig. 2B) , though it is not systematic for the better or worst states, whereas the parametric model seems to predict higher utilities than those observed in the OAB (Fig. 1B) . Table 4 shows the inference for the mean health state utility values of a sample of 20 health states. These health states were selected at random from the 99 states valued in the sample to ensure a balance of mild, moderate, and severe states. For each state, Table 4 reports the observed sample mean health state utility and the predicted mean and SD for the population mean health state utility from both nonparametric and parametric models. It shows that across the two surveys the predictive performance of the nonparametric model is better than that of the parametric model overall, with an RMSE of 0.06 for the nonparametric model and 0.07 for the parametric model for both data sets.
No state is estimated as being worse than death in either data set. Important differences, however, can be seen between the models from Table 4 . For AQL-5D, the parametric model estimates the health state utility for the pits state to be 0.4258, even though the observed average for this state is 0.3912, whereas the nonparametric model achieves a value of 0.3811. For OAB-5D, the parametric estimate was 0.6173 compared with an observed mean of 0.5656, but the nonparametric model gave 0.5464. The SDs of the predictions are larger for parametric models because they are based on the assumption that the preference function is additive in the various factors, apart from the interaction dummy term. The posterior SDs are smaller, and this is mainly because it is a model that allows uncertainty in the shape of the health state utility function.
The validity of the assumed models is examined in Figure 3 , which shows a histogram of standardized residuals across all 2455 health state valuations for the parametric model, and Figure 4 shows the corresponding standardized residuals for the nonparametric model. According to these models, we would expect these to be approximately N (0, 1). Figures 3 and 4 broadly support this, although there is some evidence of skewness, which is more obvious in Figure 3 . This is not surprising, given the negative skewness in the original TTO data at the individual level. The degree of skewness, however, is probably not high enough to invalidate the analyses in both models, which assume normally distributed errors. A better test of the validity of the model is to investigate its ability to predict the values for states that have not been used in the estimation. To do this, 10 health states were removed randomly from the estimation data, and the models fitted on data for the remaining 89 states. The observed sample means for the 10 omitted states, together with their predicted mean and SD values from the parametric and nonparametric models estimated, are compared for the reduced data set in Table 5 . It can be seen that the nonparametric model predicts the omitted data quite well and better than does the parametric model. Overall, the predictive performance of the nonparametric model is better than that of the parametric model, with RMSEs of 0.037 compared with 0.046, respectively, for the AQL-5D and 0.038 compared with 0.051 for the OAB-5D. The predicted SDs for both models are larger than those in Table 4 , because the model in Table 4 is predicting the data on which it was estimated, whereas the model in Table 5 is predicting out of sample data. The parametric standard errors are larger than the nonparametric ones, primarily because the nonparametric analysis is able to make use of other evaluations by the same respondents to estimate their individual random effects, which the frequentist analysis cannot do.
The Q-Q plots of standardized predictive errors for the 10 health states sample means are presented in Figures 5 and 6 . The dotted line on each is the fitted and corresponds to a reference line passing through first and third quartiles, which indicates whether the points are linear. The solid line corresponds to the theoretical N(0,1) distribution. Figure 5 suggests that the parametric models are not well validated, particularly for the AOB-5D.
In contrast, Figure 6 shows that nonparametric model predictions are well validated. Very similar results were obtained in five replications.
The analysis of covariates suggested that sex and age had some effect on AQL-5D health state values and experience of illness and age had some effect on OAB-5D values. Education did not have any discernible impact. As reported earlier, the age and sex distributions of respondents included in the two studies were different from those excluded and from the UK population as a whole. Therefore, we have examined the overall effect of adjusting for covariates on the values of the health states listed in Table 3 . Actual UK age and sex distributions were taken from the UK census of 2011 [28] . The resultant posterior mean health state values were found to be almost identical to those that estimated the age and sex distributions from the valuation surveys, with differences of less than 0.005 in mean health state values.
Discussion
In this article, we have applied nonparametric methods to the existing AQL-5D and OAB-5D valuation data in an attempt to overcome some of the limitations observed when a parametric approach has been used. It extends methods used to model the SF-6D and HUI2 valuation data nonparametrically [19, 22] to two condition-specific measures and applies them to TTO health state utility data. The Bayesian main-effects models estimated on two data sets have been compared with the conventional main effects model [11, 12] . The flexibility of the nonparametric 
Bayesian method to examine the effect of covariates on health state values has also been used. The nonparametric model is able to represent more accurately than the conventional parametric random-effects model the nature of individual respondent effects, the repeated measurements from each individual, and the skew distribution of individual valuations of a given state. The model also allows for respondent-level covariates to enter in a natural way as predictors of individual respondent effects.
As reported earlier, the covariates analysis showed that age and sex have strong effects on AQL-5D values and age and illness have a strong effect on OAQ-5D values. However, the overall effect of these background variables on the original posterior mean health state values after adjusting for age and sex were quite modest (typically 0.0045 or less). The descriptive content of the instruments seem to have been more important than these characteristics of the respondents examined in this article in explaining the variation in TTO values. Kharroubi at al. [21] drew a similar conclusion from their analysis of the SF-6D data.
The nonparametric model achieved improvements to the predictive ability in terms of a better RMSE and standardized predictive errors in the out of sample validation. Although the improvement in mean squared error is quite modest in this example, there are other important advantages over and above the mean difference. Our model produces 1. predictions that are much better behaved and do not violate logical consistency, 2. a utility function that better captures the lower utilities in the data for the poorest health states, and 3. posterior variances that correctly validate against the leftout data.
The extra flexibility of the nonparametric model and improved performance come at the expense of computational complexity and specialist software is needed to estimate the preference function (see [19] for details). The benefits are worth this extra given the expense of collecting good quality utility data from respondents. The programs developed for these applications can be readily adapted to other data sets with appropriate expertise.
The complexity of the modeling has little implication for those simply wishing to generate health state utility values from Asthma Quality of Life Questionnaire or Overactive Bladder Questionnaire data sets (e.g., from data collected in a clinical trial). The results can be readily applied using straightforward Excel programs that have a procedure for undertaking a simple look-up procedure.
An alternative semi-parametric approach to health state valuation for handling these problems has been developed by Mendez et al. [29] . Their approach makes no assumption on the distribution of health state valuations, allows for an undetermined amount of heterogeneity in the estimates, and accommodates covariates in a flexible way. It is important to compare our approach to that applied by Mendez et al. in the future to make best use of health state valuation data.
This article presents nonparametric models to estimate a Bayesian preference-based index for two five-dimensional health state classifications, one for asthma (AQL-5D) and the other for overactive bladder (OAB-5D). It also reports on the effect of respondent characteristics on health state valuations. The nonparametric Bayesian models are theoretically more appropriate than previously used parametric models and provide better utility estimates from the two condition-specific measures. Furthermore, the model is more flexible in estimating the effect of covariates.
